Combination procedure offers many advantages

Article

The combination of sutureless coaxial microincision cataract surgery and 23-gauge vitrectomy confers many advantages, including less wound leakage, good anterior chamber stability, safety, decreased inflammation and faster rehabilitation after surgery, according to the authors of a study published recently in Retina: The Journal of Retinal and Vitreous Diseases.

The combination of sutureless coaxial microincision cataract surgery and 23-gauge vitrectomy confers many advantages, including less wound leakage, good anterior chamber stability, safety, decreased inflammation and faster rehabilitation after surgery, according to the authors of a study published recently in Retina: The Journal of Retinal and Vitreous Diseases.

For this retrospective review, researchers from Linköping University Hospital, Linköping, Sweden, and St Erik Eye Hospital, Stockholm, reviewed outcomes and findings in 50 patients (50 eyes) who underwent coaxial microincision cataract surgery and foldable IOL implantation, combined with 23- gauge vitrectomy for a variety of indications between January 2010 and March 2012. They reviewed the indications, intraoperative/ postoperative complications and outcomes.

Their data showed the following:

  • No posterior capsule tears were seen during surgery.
  • Retinal breaks were found intraoperatively in nine eyes (18%), which were then successfully treated with laser and/or cryotherapy.
  • Corneal suture was done in six eyes (12%).
  • Sclerotomy was sutured in two left and two right eyes (total: 8%).
  • In one case, a 23-gauge vitrectomy was converted to a 20-gauge vitrectomy.

Mean postoperative intraocular pressures (IOP) were 16.7 mmHg, and hypotony, defined as an IOP > 9 mmHg) occurred in nine eyes (18%). Posterior iris synechiae were seen 2 weeks postoperatively, with an IOP of > 40 mmHg in one eye (2%), and was normalized after Nd:YAG laser iridotomy.

Fibrin reaction in the anterior chamber was seen in one eye (2%) on day 1 posteroperatively. Finally, posterior capsule opacification requiring Nd:YAG laser capsulotomy was seen in 11 eyes (22%) during follow up.

Further information on this study can be found by clicking here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.